1. Functional ultrasound and brain connectivity reveal central nervous system compromise in Trembler-J mice model of Charcot-Marie-Tooth disease.
- Author
-
Anzibar Fialho M, Martínez Barreiro M, Vázquez Alberdi L, Damián JP, Di Tomaso MV, Baranger J, Tanter M, Calero M, Negreira C, Rubido N, Kun A, and Brum J
- Subjects
- Animals, Mice, Brain diagnostic imaging, Brain physiopathology, Male, Central Nervous System diagnostic imaging, Central Nervous System physiopathology, Charcot-Marie-Tooth Disease physiopathology, Charcot-Marie-Tooth Disease diagnostic imaging, Charcot-Marie-Tooth Disease genetics, Disease Models, Animal, Ultrasonography methods, Somatosensory Cortex physiopathology, Somatosensory Cortex diagnostic imaging
- Abstract
The Charcot-Marie-Tooth-1E (CMT1E) disease is typically described as a peripheral neuropathy in humans, causing decreased nerve conduction, spastic paralysis, and tremor. The Trembler-J (TrJ) mice serve as a high fidelity model of this disease. Here, we use functional ultrasound (fUS) and functional connectivity (FC) to analyze TrJ mice's brain activity during sensory stimulation and resting state experiments against wild type (WT) mice - the healthy counterpart. fUS is an imaging technique that measures cerebral blood volume (CBV) temporal changes. We study these changes in the primary somatosensory cortex barrel field (S1BF) of both mice populations during periodic vibrissae stimulation, measuring the number of pixels that correlate to the stimulation (i.e., the size of the activation area), the average correlation of these pixels (i.e., the response strength), and the CBV's rate of change for each stimulation (i.e., the hemodynamic response). Then, we construct a FC matrix for each genotype and experiment by correlating the CBV signals from the eight cortical regions defined by the Paxinos and Franklin atlas. Our results show that TrJ mice have significantly diminished neurovascular responses and altered brain connectivity with respect to WT mice, pointing to central nervous system effects that could shift our understanding of the CMT1E disease., Competing Interests: Declarations. Competing interests: M.T. is co-founder and shareholder of Iconeous, a company which commercializes ultrasonic neuroimaging scanners. The remaining authors declare no competing interests., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF